Proton and Heavy Ion Therapy: Technical Principles and Medical Pathways in China
From Bragg Peak to clinical data of 10,000 cases, clearly explain a cutting-edge radiotherapy
Among the various options for tumor treatment, protons and heavy ions are probably the ones with the easiest names to remember and the most misunderstood. It is often described as “directional blasting”“Precise cancer killing”, was Rumor has it that “a sky-high price of one million yuan”[ [E6]]Only a very few people can afford ”. The real picture is somewhere in between: this is a radiotherapy technology with clear physical principles and rapidly accumulating clinical evidence. It has clear target groups and clear restricted areas; the cost has an open price structure, and there are accessible payment paths. The following is a complete explanation of this matter in the order of “, where is it strong, who is suitable, how far has China achieved, where is the money spent, and how is the process ”.
1. What is it: an energy release that occurs deep within the tumor
When we usually talk about radiotherapy, most of it refers to photon radiotherapy, which is to irradiate tumors with high-energy X rays. Photons are like a continuously burning torch, releasing energy from the moment the skin enters the body. After passing through the tumor, they continue to move forward until they pass out of the body. To illuminate the tumor with a sufficient dose, the normal tissue in front of the tumor must be “”, and the tissue behind the tumor cannot escape either. The trade-off between dose and damage has long been the most difficult task for radiotherapists.
Particle radiotherapy was changed to a different type “ballistic ”. Protons are positively charged particles after hydrogen atoms have stripped away their electrons. The most commonly used heavy ion in clinical practice is carbon ions. They are accelerated in a synchrotron to close to 70% of the speed of light, about 210,000 kilometers per second, and are then led out of the human body. Unlike photons, particles release only a small amount of energy while traveling, and their speed is almost constant; when it reaches a depth preset by the beam energy, its speed drops sharply, releasing most of its energy at once within a very short distance, and then the energy quickly returns to zero. This energy release curve is called “Bragg peak ”.
The Bragg peak brings a result that photons cannot achieve: there is almost no dose deposition behind the tumor, and the dose along the front of the tumor is also significantly lower than that of photons. In layman's terms, photons are “ passing through ”, and particles are [[T96] ]“ detonates upon arrival ”. The depth of the detonation point can be accurately set according to the location of the tumor. The synchrotron used by Shanghai Proton and Heavy Ion Hospital has a diameter of 21 meters, and the beam energy can be adjusted freely, precisely to place the detonation point where it is needed.
The difference between protons and heavy ions lies in “explosion accurately”[[T1 14]]In addition to “ exploded hard ”. Both have Bragg peaks, but the peaks of heavy ions are narrower, steeper, and physically more concentrated; more importantly, the relative biological effect of heavy ions is significantly higher than that of photons and protons, and they are more lethal to hypoxic cells and tumors that are insensitive to conventional rays. The popular science materials of the China Anti-Cancer Association use two metaphors to distinguish between the two: protons are like a depth bomb, which mainly relies on physical properties to determine the dose; heavy ions are like an earth-penetrating bomb, which is accurate and has stronger biological destructive power.
Regardless of protons or heavy ions, the final effect on cells is the same: the rays cause DNA double-strand breaks in the cells, and the tumor cells are unable to complete repair due to defects in repair ability and will undergo apoptosis. The difference is that the breaks caused by heavy ions are more complex and difficult to repair, which is why it is still effective for tumors that resist radiotherapy “.
2. Where are the clinical benefits
translates “ accurately ” into benefits that patients can perceive, and there are mainly four layers.
The first layer is to take away unnecessary doses from normal tissues, directly in exchange for lower short-term and long-term side effects. The more difficult the location of the tumor, the more obvious the benefits: skull base tumors are close to the brainstem and optic nerve, left breast cancer is close to the heart, central lung cancer surrounds the trachea and heart, and the spinal cord, gonads, and thyroid around children's tumors are still developing. In these scenarios, even if the intensity of photons is modulated, part of the dose will inevitably be sprinkled on vital organs; the dose of particle radiotherapy drops more steeply, which can suppress this part of the dose. Popular science information from the Chinese Anti-Cancer Association clearly states that for children with tumors that require radiotherapy, proton therapy is considered to maximize the protection of children’s future quality of life “[ [T163]] One of the gold standard ” options, which can reduce the risk of growth malformations, endocrine disorders, and second primary cancers induced by radiotherapy.
The second level allows “ dose escalation ”. Since the dose to the surrounding tissue is lower, doctors have room to increase the tumor dose to a level that is difficult to achieve with photons. The clinical significance of this is very practical for tumors such as locally advanced prostate cancer and some soft tissue sarcomas “. But dose escalation requires extremely precise calculation and evaluation, not simply increasing the number.
The third layer is non-invasive. Particle radiotherapy does not require surgery or bleeding, and provides a way to obtain radical treatment for early-stage tumor patients who are elderly, have poor cardiopulmonary function, have multiple underlying diseases, or are clearly unwilling to undergo surgery. Public information from Shanghai Proton and Heavy Ion Hospital mentions that its five-year overall survival rate for early-stage non-small cell lung cancer reaches 73.8% , and it is non-invasive and painless, making it especially suitable for this group of people.
The fourth level is a more compact treatment course. A course of conventional photon radiotherapy takes an average of about thirty irradiations; patients at Shanghai Proton and Heavy Ion Hospital receive an average of 19 irradiations, each lasting about 12 minutes. The entire course of treatment is usually completed within four to six weeks. For patients seeking medical treatment in other places or even across borders, time itself is a cost.
The limitations also need to be explained clearly. The advantages of particle radiotherapy are not equally obvious in all locations: modern photon intensity-modulated radiotherapy can already do a good job for tumors that are superficial and not surrounded by extremely sensitive organs, but the additional benefits are limited. Heavy ion equipment is scarce globally, has high construction and maintenance costs, and is bound to be more expensive than conventional radiotherapy. Long-term follow-up data for some diseases are still accumulating and cannot simply be equated to “better choice”.
Table 1 The main differences between photon, proton and heavy ion radiotherapy
|
Comparison dimensions |
Photons (X rays) |
Protons |
Heavy ions (carbon ions) |
|
Ray properties |
High energy electromagnetic waves |
Charged particles (hydrogen nuclei) |
Charged particles (carbon ions) |
|
Dose distribution |
Continuous release along the beam path, there is still dose behind the tumor |
Bragg peak, quickly returns to zero after the peak |
The peak is narrower and steeper, and there is almost no dose after the peak |
|
Relative biological effects |
Benchmark |
Slightly higher than photons |
is significantly higher than photons and protons, and is more lethal to hypoxia and tumor resistance |
|
Typical number of irradiations |
On average about 30 times |
Depends on the type of disease, generally less than photons |
usually less than protons |
|
Core advantages |
Mature technology, many institutions, low cost |
Accurate, good protection of normal tissue, obvious advantages in tumors in children and adjacent sensitive organs |
Accurately increase killing, suitable for large hypoxic tumors that are resistant to radiotherapy |
|
Main limitations |
Normal tissue is exposed to high doses and the risk of long-term side effects is greater |
has limited biological damage to photon-resistant tumors |
Equipment is scarce and expensive, and evidence for some diseases is still accumulating |
Source: Shanghai Proton and Heavy Ion Hospital official website “Technical principles ” column; Chinese Anti-Cancer Association's "Core Popular Science Knowledge for the Management of Cancer Patients in China (2026)" particle therapy section. The number of irradiations is an average value and may vary from person to person.
3. Who is suitable and who is clearly blocked
As of 2026, the types of tumors that Shanghai Proton and Heavy Ion Hospital can treat have expanded to more than 50 types, basically covering common malignant tumors among Chinese residents. What are really concentrated treatments are six types of key diseases: nasopharyngeal cancer, intracranial skull base tumors (including chordoma, chondrosarcoma, meningioma, acoustic neuroma, glioma, etc.), lung cancer, prostate cancer, breast cancer, and pancreatic cancer. These six categories of patients account for about three-quarters of the total number of patients admitted. In addition, liver cancer, esophageal cancer, thymoma, recurrent rectal cancer and other unresectable pelvic tumors, bone and soft tissue sarcomas, and childhood solid tumors are also treated. The hospital also carries out particle radiotherapy for non-tumor diseases such as wet fundus macular degeneration.
The restricted area is also clear. According to the hospital's publicly released reply in 2025, the following situations are usually not suitable: the tumor has reached an advanced stage and has metastasized to multiple organs throughout the body; hematological tumors such as leukemia and multiple myeloma; and the same site has received radiotherapy or radioactive seed implantation within six months. In addition, the patient needs to be able to maintain a prone or supine position for a long period of time, about thirty minutes, in order to complete positioning and irradiation; except for individual central nervous system tumors that can be handled exceptionally by hospital evaluation under strict conditions, pathological diagnosis is in principle required.
To determine whether you fall within the adaptation range, there is a low-cost starting point: “ through the hospital’s WeChat official account Intelligent Guidance ” for preliminary screening, or use “ cloud clinic ” to submit information for online consultation. It should be reminded that online consultation can only answer “ whether it is worth a visit ”. It cannot replace offline outpatient clinics and multidisciplinary discussions, nor can it replace the treatment itself.
4. To what extent has China achieved: a set of verifiable data
Talking about the advantages and disadvantages of technology is easy to be vague, but talking about data is more reliable. The clinical volume of particle radiotherapy in China is mainly concentrated in one institution.
Shanghai Proton and Heavy Ion Hospital, and Fudan University Cancer Hospital Proton and Heavy Ion Center, 20155Officially opened on August 8. It is the first medical institution in China and the third in the world to have both proton and heavy ion treatment technologies. It is led by the government, invested and constructed by state-owned enterprises, and managed by the Shanghai Shenkang Hospital Development Center on behalf of the Shanghai Municipal Government. It is a public municipal hospital, not a private institution. The hospital has introduced equipment from Germany's Siemens, which can independently switch protons or heavy ions according to treatment needs.
2026On November 113, the hospital treated and discharged more than 10,000 patients, which took eleven and a half years. As a comparison, similar institutions in Germany and Japan, which launched particle radiotherapy earlier in the world, took fifteen and twenty years respectively to treat 10,000 cases. The annual treatment volume of a single device has exceeded one thousand cases for many consecutive years, reaching one thousand two hundred and sixty-seven cases in 2025. Among these 10,000 patients, there were 5,139 cases of head and neck tumors, 3,192 cases of abdominal and pelvic tumors, and 1,669 cases of chest tumors. About 75% of the patients received heavy ion therapy alone or heavy ion combined with proton radiotherapy, indicating that the actual use of heavy ion technology in this hospital is very intensive.
The efficacy data comes from the 2026 version of the "Proton Heavy Ion Radiation Therapy Patient Survival Report" released by the hospital. The five-year overall survival rate of all admitted patients was 70.4%, of which the stage was 0—Ⅰ stage and Ⅱ stage patients are [[T461] respectively ]83.8% and 82.1%; Grade III and IV adverse reactions occurred during treatment The rates are 4.2% and 0.5% respectively. The hospital compared this set of data with the results published by internationally renowned cancer centers and concluded that the clinical efficacy and toxicity control of key diseases have reached the international advanced level.
Table 2 Main efficacy data for key diseases
|
Disease types and situations |
Key efficacy indicators |
Toxic side effects and notes |
|
Nasopharyngeal carcinoma (initial treatment) |
5 annual overall survival rate93.8% |
3—4 grade oral mucosal reaction incidence 7.8%; this hospital is the center with the largest number of cases of nasopharyngeal cancer treated with heavy ions in the world |
|
Nasopharyngeal carcinoma (local recurrence, simple heavy ion, first in the world) |
5 year overall survival rate45.3% |
The incidence of nasopharyngeal mucosal necrosis has dropped to 16%, which has become an internationally recognized best solution |
|
Early stage (Ⅰ) non-small cell lung cancer |
5 year overall survival rate73.8% |
85% of lung cancer patients use heavy ions; early central lung cancer 3 grade or above toxic and side effects are lower than 1% |
|
Local advanced (Ⅲ stage) non-small cell lung cancer |
5 year overall survival rate42.7% |
The incidence rate of grade 3 and above toxic side effects6.1% |
|
Pancreatic cancer |
3 year overall survival rate 33.1%, median survival time 26.8 months |
95% uses simple heavy ions; the incidence rate of late-stage 3 and above grade 1.2% |
|
Limited stage prostate cancer |
5 year overall survival rate97.2%,[ [T617]]5-year prostate-specific survival rate100% |
5-year biochemical recurrence-free survival rate88.3% , no urinary system and intestinal reactions above 2 grade |
|
Breast cancer |
5 year overall survival rate97.3% |
A total of more than 1,300 cases have been treated ; proton combined with heavy ion research has been carried out for triple-negative, HER-2-positive and other refractory types |
|
Glioblastoma (proton combined with heavy ion, an international first) |
3 annual overall survival rate38.8% |
Adverse reactions during treatment are mild and suitable for patients with high requirements for brain function protection |
|
Admit all patients |
5 year overall survival rate70.4% |
0—Ⅰ83.8%, Ⅱ82.1%;[[T6 94]]3 grade adverse reactions4.2% , 4 level 0.5% |
Data source: Shanghai Proton and Heavy Ion Hospital 2026 version of "Proton and Heavy Ion Radiotherapy Patient Survival Report" and the hospital 2026[[T71 Information is publicly released in 9]]5 and 11; the five-year breast cancer survival rate is taken from the hospital's 2025 tenth anniversary survival report. The survival rate is affected by factors such as stage, pathological type, and previous treatment. Individual differences are large and cannot be directly applied.
What supports these numbers is equipment and quality systems. The hospital is the first among similar institutions in the world to equip the treatment room with mobile online CT and optical body surface tracking systems. Relying on image-guided radiotherapy and adaptive radiotherapy technology, the beam accuracy reaches sub-millimeter level, and the dose verification pass rate is 99.3%. It is also the only proton and heavy ion hospital in China that has been independently approved for the "Radioactive Drug Use License (Category IV)". It has developed and applied six new radioactive molecular imaging probes, two of which are used to exclude lymph node metastasis without puncture and to locate hypoxic areas of tumors that are resistant to radiotherapy.
Supply capacity is still expanding. The second phase of the hospital project will start in 20259. It is planned to be completed by the end of 2028, and a new set of heavy ion system equipment and a set of high-performance proton system equipment will be added. Once completed and put into operation, the hospital is expected to become the world's largest tumor particle radiotherapy center.
From a national layout perspective, the National Health Commission has licensed more than 20 medical institutions in batches to configure proton or heavy ion radiotherapy systems, covering Beijing, Shanghai, Shandong, Henan, Hunan, Guangxi, Sichuan, Shaanxi, Gansu and other places. Among them, heavy ion systems are distributed in Jilin, Fujian, Shandong, Hubei, Sichuan, Guizhou, Shaanxi and other places. This means that “particle radiotherapy” is changing from a scarce resource in a few cities to a regionally accessible service.
5. Where the money is spent and who can share it
Cost is the most easily distorted part of cross-border medical decisions by rumors. The price structure of Shanghai Proton and Heavy Ion Hospital is public: only one course of proton and heavy ion radiotherapy is performed for the same tumor lesion, and there is no “ multiple courses of treatment[ According to [T780]]”, the cost of a single course of radiotherapy is 278,000 yuan, including 68,000 yuan for molding, positioning and radiotherapy planning, and 210,000 yuan for intra-course radiotherapy. Including hospitalization fees, examination fees, nursing fees, etc., the total cost of hospitalization for patients averages about 330,000 yuan.
Table 3 Cost structure and payment channels (Shanghai Proton and Heavy Ion Hospital)
|
Project |
Amount |
Explanation |
|
Single course radiotherapy fee |
27.8 ten thousand yuan |
Including mold positioning and radiotherapy plan 6.8 ten thousand yuan, radiotherapy within the course of treatment 21ten thousand yuan |
|
Total cost of hospitalization |
The average is about 33 million |
Including radiotherapy fees, hospitalization fees, examination fees, nursing fees, etc. |
|
Bed fee (reference) |
Triple room1500yuan/day; two people 1800yuan[[T85 8]]/ days; single room 3800[[T864] ]yuan/day |
The hospitalization period is usually 4—6 weeks, and the room type is arranged according to the current vacancy |
|
Multidisciplinary discussion (reference) |
2000—3000yuan |
All patients must undergo multidisciplinary discussion before entering the mold positioning process |
|
Other centers (Lanzhou, Wuwei) |
Single course of treatment capped 19.810,000 yuan |
20261 month 1 will implement the national unified price: The first time 4.95 ten thousand yuan, and every subsequent time 1.65 ten thousand yuan |
Data sources: Shanghai Proton and Heavy Ion Hospital 2025 public reply (course of treatment and total cost); hospital doctors’ public science information (bed fees and discussion fees, actual notifications from the hospital shall prevail); Gansu Province Wuwei Cancer Hospital Heavy Ion Center official website (other center prices).
In terms of payment, two things need to be looked at separately. First, basic medical insurance: The hospital is currently not a designated hospital for Shanghai’s basic medical insurance, and the costs related to proton and heavy ion radiotherapy cannot be reimbursed through the city’s medical insurance. The second is commercial insurance and urban customized supplementary insurance: the hospital is “Shanghai Huibao[ [T933]]” Designated hospitals have opened direct compensation services. Insured residents in this city can be reimbursed for part of the expenses based on whether they are patients with pre-existing conditions, up to 70%; The hospital also cooperates with a number of insurance institutions to launch special products for particle radiotherapy. Commercially insured patients account for 40% of the total number of patients, and has assisted nearly a thousand people “Shanghai Huibao ” insured patients have received a total of more than 130 million yuan in compensation.
In horizontal comparison, prices in mainland China are at the mid- to low-end internationally. According to public reports, a course of similar treatment in the United States costs about 900,000 yuan (as of 2015), and about 180,000 yuan in Japan (as of the same year). In China, the Lanzhou and Wuwei centers that use independent intellectual property carbon ion systems have a single treatment cap of 198,000 yuan. Behind the price difference are the differences in equipment sources, operating costs and pricing mechanisms. When choosing, it is not advisable to just look at the unit price, but to see what items are included in the quotation, how the treatment of complications is billed, and whether follow-up is included.
6. From consultation to follow-up: how to go about the whole process
The process of particle radiotherapy is longer than conventional radiotherapy, because every link must serve “ accurately ”. Understanding the process can help patients and families balance expectations and schedules.
Table 4 The main aspects of medical treatment and treatment
|
link |
Things to do |
Patients need to prepare |
|
Online pre-evaluation |
WeChat public account“Intelligent diagnosis ” Preliminary screening, Or “Cloud Clinic”Submit information for consultation |
Pathology reports, imaging reports, past treatment records |
|
outpatient clinic |
All appointments are required for registration, and the attending team will initially assess whether they belong to the suitable group |
Bring all the information required by the hospital, and patients from other places can make an appointment in advance |
|
Multidisciplinary discussion |
Radiotherapy, surgery, imaging, pathology and other disciplines jointly confirm plans and choices |
Wait for the conclusion of the discussion and make additional inspections if necessary |
|
Modeling and planning |
Position fixation, CT and MRI positioning, target area delineation, plan formulation, plan verification and quality control |
Go to the hospital as scheduled and maintain a fixed position |
|
Treatment |
Irradiated in divided doses as planned, with an average of 19 times, each time about 12 minutes, treatment course 4—6weeks |
During treatment, follow the doctor’s instructions to care for the skin in the irradiated area |
|
Follow-up |
Regularly review images and related indicators to evaluate efficacy and adverse reactions |
Keep all medical records and imaging data, and follow up with appointments |
Source: Shanghai Proton and Heavy Ion Hospital’s public medical instructions and doctor’s popular science information. The specific schedule of each link shall be subject to the notification from the hospital.
Document preparation is the part that is most likely to slow down progress. The basic materials required by the hospital include identification, surgical records, previous radiotherapy and chemotherapy records (especially the dose, frequency and irradiation range of the previous course of radiotherapy, and whether the current recurrence area falls within the original target area), CT and MRI, preferably electronic version in DICOM format; PET-CT can provide preoperative data. In terms of pathology, the original pathology report is required, and it is recommended to borrow pathological slides from the local hospital and bring them with you, usually including all stained slides and ten to fifteen white slides, because the slides need to be sent to Fudan University Affiliated Cancer Hospital for pathological consultation before admission. Borrowing films often requires a film borrowing form from the consultation unit, which can be issued by registering at the hospital in advance.
7. Five practical issues in cross-border medical treatment
For patients from overseas, medical feasibility is only the first hurdle, and there are five more hurdles to pass before implementation.
One is time. A four- to six-week course of treatment is not a long time in itself, but due to the time required for pre-assessment, multidisciplinary discussions, mold positioning and plan verification, plus travel and follow-up, the actual stay usually requires a wider window than the course of treatment. Arrange your itinerary according to the tightest version, and you will often be forced to change your itinerary due to waiting for seats or additional inspections.
The second is medical records and language. The image must be a readable DICOM file, and the pathological slides must be physical objects, both of which cannot be replaced by mobile phone photos. Cross-border patients should also prepare a structured medical record summary and translation describing the diagnosis, stage, number and time of previous treatment lines, which can significantly shorten the time for doctor evaluation.
The third is insurance. The most common misunderstanding when seeking medical treatment across borders is mistaking travel insurance for medical insurance. Planned treatments are usually not covered by ordinary travel insurance. You need to confirm in writing with the insurance company before traveling: whether the treatment is covered, whether pre-authorization is required, whether to pay directly or pay out of pocket first, and what materials are required for claims.
The fourth is visa and stay. Different nationalities and different reasons have different visa types and lengths of stay. Applications should be handled in accordance with the current standards of the Chinese embassy, consulates and immigration authorities in the local area. It is not appropriate to rely on the experience of others or the inference of the transit visa-free policy. Medical invitation letters, hospital appointment confirmations, cost estimates and other materials usually help to explain the purpose of travel, and are subject to the requirements of the embassy and consulate.
The fifth is expenses and companionship. In addition to the treatment fee, accommodation, companionship, translation, round-trip transportation, and possible extended stay are all actual expenses. The hospital is located at No. 4365 Kangxin Road in Pudong New District, Shanghai. There are many accommodation options in the surrounding area. For long-term stays, it is recommended to choose accommodation that can be walked or short-distance commuting to reduce the cost of commuting during treatment.
8. Before making a decision, answer five questions
Particle radiotherapy is not “The more advanced the better ”[[T1168] ], but “, the more matching the better ”. Before investing time and money, it’s recommended to answer five questions in order.
First, whether the pathology and staging are clear. Without pathology, most treatments are impossible; staging determines whether the treatment goal is radical cure or control. Second, whether the lesion is localized. For advanced patients who have metastasized to multiple organs throughout the body, local radiotherapy cannot change the overall course of the disease, and systemic treatment should be considered first. Third, whether the area has been photographed. Areas that have received radiotherapy or radioactive seed implantation within six months are usually no longer suitable for repeat seed radiotherapy. Fourth, whether there are more mature alternatives. Surgery, photon radiotherapy, and systemic therapy are still standard solutions for many diseases. Particle radiotherapy is one of the more precise tools, not the only answer. Fifth, whether the cost and stay are affordable. This is not only an economic issue, but also a problem of continuity of treatment —— Interruption due to cost will reduce the efficacy.
At the same time, we should be wary of three widely circulated statements. First, “ proton heavy ions cost millions of dollars ”. The public price in Shanghai is 278,000 yuan for a single course of treatment, and the average total hospitalization cost is about 330,000 yuan, which is far from the rumors. Second, “ requires several courses of treatment ”. Only one course of treatment is performed for the same lesion. The so-called multiple courses of treatment is a misinformation. Third, “This is a private high-end hospital ”. The hospital is built under the leadership of the government and managed by the Shenkang Hospital Development Center. It is a public municipal hospital and implements the same multidisciplinary discussion and quality control as public hospitals. On the other hand, if any institution guarantees the admission and treatment of “”“Guaranteed efficacy”“Guarantee visa”Make a commitment , all worthy of vigilance —— None of these can be decided by the intermediary or platform.
Conclusion
The real value of proton heavy ion lies not in how cutting-edge it sounds, but in that it solves the most difficult problem in radiotherapy ——[ [T1246]]The trade-off between efficacy and normal tissue damage—— has been pushed one step forward. This step means a lot to some people: patients with skull base tumors, left-sided breast cancer patients who need to protect their hearts, growing children, elderly patients with inoperable early-stage lung cancer. For others, it has limited marginal benefit and conventional treatment is sufficient.
To determine which category you belong to, you do not rely on slogans, but on pathology, stage, location, past treatment history and a set of data that can be verified. After clarifying these items and then discussing whether it is worth traveling across cities or borders, the answer will usually be much clearer.
Source
[1] Shanghai Proton and Heavy Ion Hospital official website: https://www.sphic.org.cn
[2] Shanghai Proton and Heavy Ion Hospital: The first proton and heavy ion hospital in China leads innovation and benefits more than 10,000 patients (2026[[T127 8]]Year11Month4 ): https ://www.sphic.org.cn/tzgg/info_6.aspx?itemid=0
[3] Shanghai Proton and Heavy Ion Hospital: Treatment advantages (technical principles): [[T130 2]]https://www.sphic.org.cn/zlys/index_22.aspx
[4] People's Daily Online: Shanghai Proton and Heavy Ion Hospital releases report The advantages of heavy ion technology are highlighted (2026[[T13 13]]5month9day):[ [T1320]]https://sh.people.com.cn/n2/2026/0509/c176737-41575320.html
[5] The Paper: Shanghai Proton and Heavy Ion Hospital Operation 11, particle radiotherapy patients 5[[T1336] ]The annual overall survival rate exceeds 70%(20265month8day): [[T1 356]]https://m.thepaper.cn/newsDetail_forward_33123092
[6] Shangguan News: It has been ten years since the Proton and Heavy Ion Hospital opened. You may want to know these questions (20254month): http://m.toutiao.com/group/7490393702385353250/
[7] Chinese Anti-Cancer Association: "Core popular science knowledge on the management of cancer patients in China (2026)" Particle therapy: [[T138 8]]http://www.caca.org.cn/system/2026/03/30/030269522.shtml
[8] Fudan University Shanghai Medical College: Shanghai Proton and Heavy Ion Hospital has been in operation for ten years, setting a benchmark for particle radiotherapy “China ”(20255[ [T1410]]month9day): https://shmc.fudan.edu.cn/news/2025/0509/c1891a145294/page.htm
[9] National Health Commission: List of licenses for heavy ion proton radiotherapy systems: https://www.n hc.gov.cn/cms-search/downFiles/794414a316444afaa1715fb7008a2056.pdf
[10] Gansu Province Wuwei Cancer Hospital Wuwei Heavy Ion Center official website: https://www.wwzlz.cn/
[11] Good Doctor Online: Shanghai Proton and Heavy Ion Hospital Popular Science Number (Instructions on Treatment Process and Fees): https://jiangkanghao.haodf.com/206810.html
[12] Health Times: Proton heavy ion targeted tumor elimination (2015[[T14 60]]7month27 Japan): http://paper.people.com.cn/jksb/html/2015-07/27/content_1593037.htm
Note: This article is based on public information and is for information reference. It does not constitute medical advice, diagnostic basis or promise of efficacy. Whether proton and heavy ion therapy is suitable for treatment must be judged by a qualified medical institution through multidisciplinary evaluation; the cost and payment policy shall be subject to the current announcement by the institution.
